196 related articles for article (PubMed ID: 17318320)
1. Active ocular toxoplasmosis in Turkish patients: a report on 109 cases.
Tugal-Tutkun I; Corum I; Otük B; Urgancioglu M
Int Ophthalmol; 2005 Dec; 26(6):221-8. PubMed ID: 17318320
[TBL] [Abstract][Full Text] [Related]
2. Ocular toxoplasmosis: clinical features and prognosis of 154 patients.
Bosch-Driessen LE; Berendschot TT; Ongkosuwito JV; Rothova A
Ophthalmology; 2002 May; 109(5):869-78. PubMed ID: 11986090
[TBL] [Abstract][Full Text] [Related]
3. Clinical features of ocular toxoplasmosis in Korean patients.
Park YH; Han JH; Nam HW
Korean J Parasitol; 2011 Jun; 49(2):167-71. PubMed ID: 21738273
[TBL] [Abstract][Full Text] [Related]
4. Clinical manifestation and prognosis of active ocular toxoplasmosis in Iran.
Kianersi F; Naderi Beni A; Naderi Beni Z
Int Ophthalmol; 2012 Dec; 32(6):539-45. PubMed ID: 22733253
[TBL] [Abstract][Full Text] [Related]
5. Outbreak of acquired ocular toxoplasmosis involving 248 patients.
Balasundaram MB; Andavar R; Palaniswamy M; Venkatapathy N
Arch Ophthalmol; 2010 Jan; 128(1):28-32. PubMed ID: 20065213
[TBL] [Abstract][Full Text] [Related]
6. Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis.
Soheilian M; Sadoughi MM; Ghajarnia M; Dehghan MH; Yazdani S; Behboudi H; Anisian A; Peyman GA
Ophthalmology; 2005 Nov; 112(11):1876-82. PubMed ID: 16171866
[TBL] [Abstract][Full Text] [Related]
7. Prevalence, clinical characteristics, and causes of vision loss in patients with ocular toxoplasmosis.
London NJ; Hovakimyan A; Cubillan LD; Siverio CD; Cunningham ET
Eur J Ophthalmol; 2011; 21(6):811-9. PubMed ID: 21374556
[TBL] [Abstract][Full Text] [Related]
8. Toxoplasmic Retinochoroiditis: Clinical Characteristics and Visual Outcome in a Prospective Study.
Aleixo AL; Curi AL; Benchimol EI; Amendoeira MR
PLoS Negl Trop Dis; 2016 May; 10(5):e0004685. PubMed ID: 27136081
[TBL] [Abstract][Full Text] [Related]
9. Multiple cases of acquired toxoplasmosis retinitis presenting in an outbreak.
Burnett AJ; Shortt SG; Isaac-Renton J; King A; Werker D; Bowie WR
Ophthalmology; 1998 Jun; 105(6):1032-7. PubMed ID: 9627653
[TBL] [Abstract][Full Text] [Related]
10. Clinical pattern of ocular toxoplasmosis treated in a referral centre in Serbia.
Kovačević-Pavićević D; Radosavljević A; Ilić A; Kovačević I; Djurković-Djaković O
Eye (Lond); 2012 May; 26(5):723-8. PubMed ID: 22361847
[TBL] [Abstract][Full Text] [Related]
11. Assessment of ocular toxoplasmosis patients reported at a tertiary center in the northeast of Iran.
Hosseini SM; Moghaddas E; Sharifi K; Dadgar Moghaddam M; Shamsian SA
Int Ophthalmol; 2018 Dec; 38(6):2527-2533. PubMed ID: 29335806
[TBL] [Abstract][Full Text] [Related]
12. Ocular Involvement Following an Epidemic of Toxoplasma gondii Infection in Santa Isabel do Ivaí, Brazil.
Silveira C; Muccioli C; Holland GN; Jones JL; Yu F; de Paulo A; Belfort R
Am J Ophthalmol; 2015 Jun; 159(6):1013-1021.e3. PubMed ID: 25743340
[TBL] [Abstract][Full Text] [Related]
13. Ocular toxoplasmosis: phenotype differences between toxoplasma IgM positive and IgM negative patients in a large cohort.
Ajamil-Rodanes S; Luis J; Bourkiza R; Girling B; Rees A; Cosgrove C; Pavesio C; Westcott M
Br J Ophthalmol; 2021 Feb; 105(2):210-215. PubMed ID: 32345603
[TBL] [Abstract][Full Text] [Related]
14. Monitoring of visual field over 6 months after active ocular toxoplasmosis.
Blot J; Aptel F; Chumpitazi BFF; Gain P; Vasseneix C; Savy O; Bouillet L; Pelloux H; Chiquet C
Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1481-1488. PubMed ID: 31037491
[TBL] [Abstract][Full Text] [Related]
15. The antitoxoplasma gondii antibodies incidence to the different ocular diseases patients cases of human ocular toxoplasmosis infections in Romania.
Teodorescu C; Teodorescu I; Raneti C; Dumitrica DM; Stefan C
Oftalmologia; 2008; 52(4):88-94. PubMed ID: 19354169
[TBL] [Abstract][Full Text] [Related]
16. Ocular impairment of toxoplasmosis.
Antoniazzi E; Guagliano R; Meroni V; Pezzotta S; Bianchi PE
Parassitologia; 2008 Jun; 50(1-2):35-6. PubMed ID: 18693554
[TBL] [Abstract][Full Text] [Related]
17. Ocular toxoplasmosis after the fifth decade.
Labalette P; Delhaes L; Margaron F; Fortier B; Rouland JF
Am J Ophthalmol; 2002 Apr; 133(4):506-15. PubMed ID: 11931784
[TBL] [Abstract][Full Text] [Related]
18. Impact of gender on clinical features and outcomes of ocular toxoplasmosis.
Lyons MR; Arantes T; Vieira BR; Furtado JM; Smith JR
Br J Ophthalmol; 2024 May; 108(5):710-714. PubMed ID: 37225390
[TBL] [Abstract][Full Text] [Related]
19. Ocular Toxoplasmosis in a Tertiary Referral Center in Sydney Australia-Clinical Features, Treatment, and Prognosis.
Yates WB; Chiong F; Zagora S; Post JJ; Wakefield D; McCluskey P
Asia Pac J Ophthalmol (Phila); 2019; 8(4):280-284. PubMed ID: 31369405
[TBL] [Abstract][Full Text] [Related]
20. Ocular manifestations in congenital toxoplasmosis.
Kodjikian L; Wallon M; Fleury J; Denis P; Binquet C; Peyron F; Garweg JG
Graefes Arch Clin Exp Ophthalmol; 2006 Jan; 244(1):14-21. PubMed ID: 15906073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
